Literature DB >> 20200816

Acute hyperhomocysteinemia impairs endothelium function in subjects with type 2 diabetes mellitus.

J Doupis1, I Eleftheriadou, A Kokkinos, D Perrea, S Pavlatos, A Gonis, N Katsilambros, N Tentolouris.   

Abstract

The objective of the present study was to examine the effect of acute, methionine-induced hyperhomocysteinemia (HHCY) on endothelial function and indices of arterial stiffness in subjects with type 2 diabetes mellitus (T2DM). A total of 30 subjects with T2DM, free of macrovascular disease were examined in a crossover study. L-methionine (M) (0.1 g/kg) and water (W) load were given in random order with an interval of about 1 week in between. Endothelial function was assessed by flow-mediated vasodilation (FMD). Arterial stiffness was assessed by determination of augmentation index (AI). Measurements were performed in the fasting state, 1, 2 and 3 h after the M or the W load. Total plasma homocysteine (HCY) levels did not change after W administration, while M administration resulted in a significant increase in HCY concentrations at 3 h. FMD throughout the experiment expressed as area under the curve (AUC) was significantly lower after the M than after the W load. Consistent with impairment in endothelial function, the AUC of AI was significantly higher after the M than after the W administration. Acute HHCY impairs endothelial function and increases arterial stiffness in patients with T2DM. This effect is probably mediated by a reduction of nitric oxide bioavailability in endothelium. J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200816     DOI: 10.1055/s-0030-1248290

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  5 in total

Review 1.  Metabolomics of Arterial Stiffness.

Authors:  Kaido Paapstel; Jaak Kals
Journal:  Metabolites       Date:  2022-04-20

2.  CpG-SNP site methylation regulates allele-specific expression of MTHFD1 gene in type 2 diabetes.

Authors:  Manik Vohra; Prabha Adhikari; Sydney C D' Souza; Shivashankar K Nagri; Shashikiran Umakanth; Kapaettu Satyamoorthy; Padmalatha S Rai
Journal:  Lab Invest       Date:  2020-04-01       Impact factor: 5.662

Review 3.  Methylenetetrahydrofolate reductase gene polymorphism and risk of type 2 diabetes mellitus.

Authors:  Jian-Hong Zhong; A Chapin Rodríguez; Na-Na Yang; Le-Qun Li
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

4.  Scutellarin Reduce the Homocysteine Level and Alleviate Liver Injury in Type 2 Diabetes Model.

Authors:  Yiyu Wang; Xiaoming Fan; Biao Fan; Kerong Jiang; Haoxin Zhang; Feng Kang; Hui Su; Danshan Gu; Shude Li; Shaofang Lin
Journal:  Front Pharmacol       Date:  2020-12-11       Impact factor: 5.810

5.  A Meta-Analysis of Association between Methylenetetrahydrofolate Reductase Gene (MTHFR) 677C/T Polymorphism and Diabetic Retinopathy.

Authors:  Shasha Luo; Furu Wang; Chao Shi; Zhifeng Wu
Journal:  Int J Environ Res Public Health       Date:  2016-08-10       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.